The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Skvortsova K.N.

City Clinical Hospital No. 4, 614107, Perm, Russia

Starikova N.L.

Permskaia gosudarstvennaia meditsinskaia akademiia

Features of diagnostic transcranial magnetic stimulation in dependence on personal characteristics in patients with medication-overuse headache

Authors:

Skvortsova K.N., Starikova N.L.

More about the authors

Journal: Russian Journal of Pain. 2020;18(1): 10‑14

Read: 736 times


To cite this article:

Skvortsova KN, Starikova NL. Features of diagnostic transcranial magnetic stimulation in dependence on personal characteristics in patients with medication-overuse headache. Russian Journal of Pain. 2020;18(1):10‑14. (In Russ.)
https://doi.org/10.17116/pain20201801110

Recommended articles:
The follow-up examination of children with breath-holding spells. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):76-80
Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107

References:

  1. Stajner TDzh, MakGregor EA, Devids PT. Evropejskie principy vedeniya pacientov s naibolee rasprostranennymi formami golovnoj boli v obshchej praktike. Prakticheskoe rukovodstvo dlya vrachej. Per. s angl. Azimovoj YuE, Osipovoj VV. M.: OOO «OGGI. Reklamnaya produkciya»; 2010. (In Russ.)
  2. Naprienko MV, Filatova EG. Application katadolon in the treatment aboutuse headache. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2006;10:38-40. (In Russ.)
  3. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. The Lancet. Neurology. 2004;3:475.
  4. Sergeev AV, Parfenov VA. Drug-induced headache: Practical recommendations. Medicinskij sovet. 2018;1:26-32. (In Russ.)
  5. Schwarz A, Farber U, Glaeske G. Daten zu Analgetikakonsum und Analgetikanephropathie in der Bundesrepublik. Das Öffentliches Gesundheitswesen. 1985;47:298.
  6. Relja G, Granato A, Antonello M, Zorzon M. Headache induced by chronic substance use: analysis of medication overused and minimum dose required to induce headache. Headache. 2004;44(2):148-153.
  7. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106(1-2):81-89.
  8. Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Barré J, Andrée C. The impact of headache in Europe: principal results of the Eurolight project. Journal of Headache and Pain. 2014;15:31. https://doi.org/10.1186/1129-2377-15-31
  9. Osipova VV, Tabeeva GR. Pervichnye golovnye boli: diagnostika, klinika, terapiya. Prakticheskoe rukovodstvo. M.: Medicinskoe informacionnoe agentstvo; 2014. (In Russ.)
  10. Feoktistov AP, Filatova EG, Vein AM. Psychophysiological features of abuse headache. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2002;10:13-17. (In Russ.)
  11. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. The Lancet. Neurology. 2010;9(4):391-401.
  12. The International Classification of Headache Disorders, 3rd edition. Cephalalgia: an International Journal of Headache. 2018;38(1):1-211. https://doi.org/10.1177/0333102417738202
  13. Starikova NL. Quality of life, coping strategies and personal features of patients in primary headache. Rossijskij zhurnal boli. 2011;2:38-43 (In Russ.)
  14. Ayzenberg I, Katsarava Z, Sborovski A, Chernysh M, Osipova V, Tabeeva G, Yakhno N, Steiner TJ; Lifting the Burden. The prevalence of primary headache disorders in Russia: A countrywide survey. Cephalalgia: an International Journal of Headache. 2012;32(5):373-381. https://doi.org/10.1177/0333102412438977
  15. Westergaard ML, Glűmer C, Hansen EH, Jensen RH. Medication overuse, healthy lifestyle behavior and stress in chronic headache: results from a population-based representative survey. Cephalalgia: an International Journal of Headache. 2016;36(1):15-28. https://doi.org/10.1177/0333102415578430
  16. Chanraud S, Di Scala G, Dilharreguy B, Schoenen J, Allard M, Radat F. Brain functional connectivity and morphology changes in medication-overuse headache: clue for dependence-related processes? Cephalalgia: an International Journal of Headache. 2014;34(8):605-615. https://doi.org/10.1177/0333102413519514
  17. Shevchenko VS, Artemenko AR, Kurenkov AL, Brzhiljanski MA, Buschkow FA. Estimation of cortical excitability in patients with chronic migraine during treatment with botuline toxine A-type. Rossijskij zhurnal boli. 2018;4:55-60. (In Russ.)
  18. Nikitin SS. Magnitnaya stimulyaciya v diagnostike i lechenii boleznej nervnoj sistemy. Rukovodstvo dlya vrachej. M.: SASHKO; 2003. (In Russ.)
  19. Terao Y, Ugawa Y. Basic mechanisms of TMS. Journal of Clinical Neurophysiology. 2002;19:322-343.
  20. Belova AN, Baldova SN. Transcranial magnetic stimulation: clinical use and scientific perspectives. Uspehi sovremennogo estestvoznania. 2015;9(1):34-42. (In Russ.)
  21. Sevel LS, Letzen JE, Staud R, Robinson ME. Interhemispheric dorsolateral prefrontal cortex connectivity is associated with individual differences in pain sensitivity in healthy controls. Brain Connectivity. 2016;6(5):357-364. https://doi.org/10.1089/brain.2015.0405

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.